Internal Medicine, Endocrinology, Diabetes, & Metabolism · Greenwood, IN
NPI
1871751461
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1703 W Stones Crossing Rd Ste 200
Greenwood, IN, 46143
Phone (317) 859-3737
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
2,408 services
Medicare patients, 2024
471
Average age 72
Drug cost, 2024
$3.5M
6,703 prescriptions
Company payments, 2025
$76.43
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy J Shoemaker was code J0897 (injection, denosumab, 1 mg), 1,080 times for 13 patients. In total Timothy J Shoemaker billed 2,408 services in 14 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,080 | 13 | $20.17 | $22K |
| 99214 Office E&M - Established | Office | 391 | 270 | $76.64 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 319 | 97 | $56.76 | $18K |
| 83036 Blood Count | Office | 219 | 168 | $9.48 | $2,077 |
| 99214 Office E&M - Established | Facility | 161 | 145 | $69.30 | $11K |
| 99222 Hospital E&M - Initial | Facility | 69 | 69 | $93.07 | $6,422 |
| 95251 Test - Miscellaneous | Office | 58 | 45 | $24.50 | $1,421 |
| 99204 Office E&M - New | Office | 34 | 34 | $104.34 | $3,548 |
| 95251 Test - Miscellaneous | Facility | 34 | 34 | $23.64 | $804 |
| 96372 Injection Administration | Office | 18 | 13 | $10.56 | $190 |
| 99204 Office E&M - New | Facility | 12 | 12 | $89.91 | $1,079 |
By year: 2022 $102K for 2,649 services; 2023 $104K for 2,604 services; 2024 $97K for 2,408 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 219 | 168 | $9.48 | $2,077 |
Medicare prescription drug claims, 2024
In 2024, the drug Timothy J Shoemaker prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 604 prescriptions and refills. In total Timothy J Shoemaker wrote 6,703 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 604 | 833 | 139 | $896K |
| Levothyroxine Sodium Generic | 517 | 1,520 | 166 | $4,928 |
| Ozempic Semaglutide | 382 | 596 | 115 | $571K |
| Metformin Hcl Er Metformin Hcl | 380 | 986 | 135 | $3,492 |
| Jardiance Empagliflozin | 376 | 782 | 104 | $452K |
| Metformin Hcl Generic | 323 | 863 | 98 | $2,215 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 291 | 764 | 112 | $50K |
| Farxiga Dapagliflozin Propanediol | 250 | 498 | 65 | $281K |
| Atorvastatin Calcium Generic | 226 | 621 | 79 | $1,867 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 211 | 489 | 84 | $30K |
| Humalog Kwikpen U-100 Insulin Lispro | 191 | 416 | 72 | $105K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 172 | 303 | 64 | $71K |
| Glimepiride Generic | 145 | 415 | 50 | $953 |
| Synthroid Levothyroxine Sodium | 127 | 334 | 41 | $14K |
| Gabapentin Generic | 123 | 314 | 45 | $2,087 |
Brand drugs: 3,754 claims; generic drugs: 2,360 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy J Shoemaker $76.43 ($76.43 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $76.43.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 2 | $76.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.